glp-1 agonist cardiovascular outcomes and mortality with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia GLP-1 receptor agonists and cardiorenal
Description
doi:10.1007/s13300-020-00981-0 21
Platelets, fragments of megakaryocytes, contain abundant information related to the central nervous system
& Boland, C
Multiple cost-reduction methods can address these financial barriers effectively
(2020, March)
doi: 10.2337/dc10-1949
